Ortho-Novum (Norethindrone / Mestranol) - Summary

ORTHO-NOVUM SUMMARY

ORTHO-NOVUM ^® Tablets
(norethindrone/ethinyl estradiol)
and MODICON ^® Tablets
(norethindrone/ethinyl estradiol)

The following product is a combination oral contraceptive containing the progestational compound norethindrone and the estrogenic compound mestranol: ORTHO-NOVUM^® 1/50: Each yellow tablet contains 1 mg of norethindrone and 0.05 mg of mestranol.

Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptive products such as ORTHO-NOVUM 1/50, which contains 50 mcg of estrogen, should not be used unless medically indicated.

ORTHO-NOVUM NEWS HIGHLIGHTS

Media Articles Related to Ortho-Novum (Norethindrone / Mestranol)

Blogs Comment On Election-Related Reproductive Rights Issues, World Contraception Day, HHS Rule
Source: Sexual Health / STDs News From Medical News Today [2008.09.29]

'Extended Cycle' Contraception Garners More Interest
Source: MedicineNet Birth Control Specialty [2008.08.25]

Male Contraception: Progress Slow but Steady
Source: MedicineNet Vasectomy Specialty [2008.04.14]

Bristol MP And Health Minister Opens City's New Sexual Health Centre, England
Source: Sexual Health / STDs News From Medical News Today [2008.10.03]

Palin Discusses Stance On Abortion Rights, EC During Interview
Source: Abortion News From Medical News Today [2008.10.02]

more>>

Published Studies Related to Ortho-Novum (Norethindrone / Mestranol)

Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. [2003.04]

Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial. [2000.05]

A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol. [1999.11]

Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone. [1998.11]

Bioequivalence of two oral contraceptive drugs containing norethindrone and ethinyl estradiol. [1989.11]

more>>

Clinical Trials Related to Ortho-Novum (Norethindrone / Mestranol)

Study of Loestrin 24(24 Days of "Real" Pills) Fe Versus Loestrin 1/20 (21 "Real" Pills) [Active, not recruiting]

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women [Active, not recruiting]

Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women [Not yet recruiting]

Safety of Estrogens in Lupus: Birth Control Pills [Completed]

A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers [Active, not recruiting]

more>>